Showing results (731-740 of 3,789) with videos related to
Sort By:
Pageof 379
Oncoimmunology|January 27, 2017
Transcriptional and metabolic reprogramming induce an inflammatory phenotype in non-medullary thyroid carcinoma-induced macrophagesRob J W Arts, Theo S Plantinga, Sander Tuit, et al.Oncoimmunology|January 27, 2017
Regulation of myeloid cells by activated T cells determines the efficacy of PD-1 blockadeNina Eissler, Yumeng Mao, David Brodin, et al.Oncoimmunology|January 27, 2017
Hypoxia and antitumor CD8+ T cells: An incompatible alliance?Romain Vuillefroy de Silly, Pierre-Yves Dietrich, Paul R WalkerOncoimmunology|January 27, 2017
IL-15 enhances the antitumor effect of human antigen-specific CD8+ T cells by cellular senescence delayJinsheng Weng, Kelsey E Moriarty, Flavio Egidio Baio, et al.Oncoimmunology|January 27, 2017
Targeting the MAPK and PI3K pathways in combination with PD1 blockade in melanomaMarcel A Deken, Jules Gadiot, Ekaterina S Jordanova, et al.Oncoimmunology|January 27, 2017
T-helper cell receptors from long-term survivors after telomerase cancer vaccination for use in adoptive cell therapyJon Amund Kyte, Gustav Gaudernack, Anne Faane, et al.Oncoimmunology|January 27, 2017
CD4+CD25hiCD127- Treg and CD4+CD45R0+CD49b+LAG3+ Tr1 cells in bone marrow and peripheral blood samples from children with neuroblastomaFabio Morandi, Sarah Pozzi, Sebastiano Barco, et al.Oncoimmunology|January 27, 2017
Clinical implication of tumor-associated and immunological parameters in melanoma patients treated with ipilimumabV Damuzzo, S Solito, L Pinton, et al.Oncoimmunology|January 27, 2017
CAR-T cell therapy in gastrointestinal tumors and hepatic carcinoma: From bench to bedsideQi Zhang, Zimu Zhang, Meiyu Peng, et al.Oncoimmunology|April 14, 2017
Combining therapeutic antibodies using basiliximab and etanercept for severe steroid-refractory acute graft-versus-host disease: A multi-center prospective studyYamin Tan, Haowen Xiao, Depei Wu, et al.Pageof 379